Overview Locations Research and Clinical Trials Annual Reports Alvin Levine Memorial
Types of Cancer Treated
Surgical Oncology Team Learn About Surgical Oncology
Medical Oncology Team Learn About Medical Oncology
Radiation Oncology Team Learn About Radiation Oncology
Radiation Oncology Department CyberKnife® TrueBeam Brachytherapy Stereotactic Radiosurgery IMRT Radioimmunitive Therapy
Forms for New Cancer Institute Patients
Patient Programs Cancer Survivorship Palliative Care Program Patient Education Cancer Support Services
Accommodations Dining Directions FAQs Hackerman-Patz House Important Phone Numbers Map Parking Pharmacy Retail Shops Visiting Hours Wireless Internet For more information, click here.
Accommodations Dining Directions FAQs Gift Shop Important Phone Numbers Map Parking Pharmacy Visiting Hours Wireless Internet For more information, click here.
Research and Clinical Trials
LifeBridge Health Development Contact Us Development News Donate Now Grateful Patient Stories Special Events Ways to Give
Volunteer at Sinai Hospital Volunteer at Northwest Hospital Volunteer at Levindale Volunteer at Courtland Gardens
ECOG E1609: A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon α-2b for Resected High-risk Melanoma. PI: Mukund Didolkar, M.D. Clinical Research Coordinators Judy Bosley, RN Jbosley@lifebridgehealth.org Pamela Nickoles, RN pnickole@lifebridgehealth.org Paulette Ridgely, RN pridgely@lifebridgehealth.org Regulatory Coordinator Melissa Loomis mloomis@lifebridgehealth.org Clinical Research Associate Rosemarie Bonvegna rbonvegn@lifebridgehealth.org Sinai Hospital of Baltimore 2401 West Belvedere Ave. Baltimore, Maryland 21215, (T) 410-601-6120 (F) 410-601-4714